Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis

Andre N. Abrunhosa-Branquinho, Raquel Bar-Deroma, Sandra Collette, Enrico Clementel, Yan Liu, Coen W. Hurkmans, Loic Feuvret, Karen Van Beek, Martin van den Bent, Brigitta G. Baumert, Damien C. Weber

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)292-298
Number of pages7
JournalRadiotherapy and Oncology
Volume127
Issue number2
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • Radiotherapy
  • EORTC
  • RTQA
  • Anaplastic glioma
  • Individual case review
  • Phase III trial
  • CLINICAL-TRIAL
  • PHASE-III
  • NECK-CANCER
  • GLIOBLASTOMA
  • SURVIVAL
  • CONCOMITANT
  • THERAPY
  • HEAD

Cite this